NASDAQ · Biotechnology

ALMS (ALMS) Stock

$26.38 -2.40% NASDAQ: ALMS Healthcare

Valuation

MetricValue
Price$26.38
Market Cap$3.26B
P/E Ratio-7.40
P/B Ratio8.65
P/S Ratio309.97
EPS (TTM)$-2.86
52-Week High$30.63
52-Week Low$2.76
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-80.73%
ROA-58.98%
ROCE-141.86%
Gross Margin-1779.17%
Operating Margin-1779.17%
Net Margin-28.26%
Debt/Equity0.06
Current Ratio4.36

Annual Financials (USD)

Metric2022202320242025
Revenue$0$0$0$24.0M
Operating Profit$-114.0M$-158.0M$-301.0M$-427.0M
Net Profit$-112.0M$-155.0M$-294.0M$-243.0M
EPS$-14.93$-2.99$-10.38$-2.86
Op Margin———-1776.3%

Balance Sheet (USD)

Metric2022202320242025
Total Assets$108.0M$90.0M$341.0M$412.0M
Total Liabilities$303.0M$429.0M$81.0M$111.0M
Cash$26.0M$46.0M$170.0M$90.0M
Borrowings$2.0M$33.0M$31.0M$37.0M

Latest News

Stifel and Guggenheim Stay Bullish on Alumis (ALMS) Insider Monkey · Jul 1, 2026 Analyst Sentiment On Alumis (ALMS) Remains Strong Following Q1 Results And Envudeucitinib Pipeline Advancements Insider Monkey · May 29, 2026 This Biotech Stock Is Up 355%. One Fund Added a $169 Million Position Last Quarter Motley Fool · May 24, 2026 Is Alumis (ALMS) Trading Short-Term Revenue for a Leaner, More Focused Business Model? Simply Wall St. · May 20, 2026 Dyne Therapeutics Is Up 40%, but One Biotech Fund Just Disclosed Selling $14 Million Worth of Shares Motley Fool · May 19, 2026

Cash Flow (USD)

Metric2022202320242025
Operating Cash Flow$-108.0M$-130.0M$-255.0M$-370.0M
Investing Cash Flow$-71.0M$56.0M$-116.0M$287.0M
Financing Cash Flow$2.0M$0$41.0M$0
Net Cash Flow$-75.0M$20.0M$123.0M$-80.0M
Free Cash Flow$-110.0M$-134.0M$-257.0M$-370.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-14.48%
Quick Ratio7.51
Interest Coverage—
Return 1Y760.12%
Return 3Y—
Return 5Y—

Ownership

Insiders Held0.62%
Institutions Held100.29%
Institutions Float Held100.91%
Institutional HolderSharesReport Date
Blackrock Inc.7,170,8682026-03-31
Deep Track Capital, Lp6,772,5952026-03-31
Samsara BioCapital, LLC6,345,2192026-03-31
Foresite Capital Management V, LLC5,896,9952026-03-31
venBio Partners LLC4,528,4082026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADCTADC Therapeutics S.A. $1.19 +3.48% -1.09 $151.36M 0.00%
BCYCBicycle Therapeutics plc $4.22 +0.24% -1.34 $292.84M 0.00%
ETON $45.49 +7.53% -178.00 $1.25B 0.00%
FULC $3.73 +0.13% -5.17 $201.56M 0.00%
LCTX $1.13 -0.88% -17.61 $281.71M 0.00%

About ALMS

ALMS stock trades at $26.38 with a market capitalization of $3.26B. The stock is valued at a price-to-earnings (P/E) ratio of -7.40, price-to-book of 8.65, price-to-sales of 309.97. Over the past 52 weeks the stock has ranged between $2.76 and $30.63, and currently trades 13.9% below its 52-week high.

On profitability, ALMS generates a return on equity (ROE) of -80.73%, return on capital employed of -141.86%, an operating margin of -1779.17%, a net profit margin of -28.26%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides